Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |